The S&P 500 index has had a remarkable year in 2024, with an impressive projected increase of around 23.8%. This significant rise outstrips the average annual growth rate of 11% that was observed from 2014 to 2023, showcasing a stark recovery in the equities marketHowever, the gains this year have not been evenly distributed among the sectors, presenting a clear divide in performanceWhile the communications sector has seen over a 40% increase, the materials sector has experienced a decline of nearly 2%. The disparity in performance emphasizes the volatility and unpredictability of the current market landscape.

Drilling down into the individual stocks within the index, a glaring contrast highlights the divergence within the marketSome stocks have soared by remarkable amounts—over 300% in certain instances—while others have taken a significant nosedive of more than 60%. This variance has created a landscape where investors must be increasingly discerning about their choices

Advertisements

Three stocks, in particular, stand out as the worst performers of the year, namely Walgreens Boots Alliance, Intel, and Moderna.

Walgreens Boots Alliance is at the forefront of disappointing performances, with its stock price plummeting over 64%. This downturn positions the company on track to record the largest annual decline in its history, enduring its eighth year of stock price declines in the last nine yearsThe challenges facing Walgreens are multifaceted, particularly in its retail pharmacy segment, which has encountered a series of obstaclesAn intensifying competitive landscape has fostered a relentless price and service war among peers, squeezing profit marginsAt the same time, disruptions in the pharmaceutical supply chain, fueled by various factors, have resulted in unreliable product availability, leading to significant customer attrition.

This culminated in a notable contraction of market confidence, vividly reflected in the dramatic fluctuations of its stock price

Advertisements

In June, the company released its third-quarter earnings report, revealing dismal revenue and profit figures, which triggered a catastrophic single-day stock crash exceeding 20%. However, a glimmer of hope appeared when news emerged earlier this month about a potential acquisition by private equity firm Sycamore, reigniting investor optimism and leading to a substantial stock surge of approximately 20% in a single dayThe narrative surrounding Walgreens is underscored by its recent removal from the Dow Jones Industrial Average earlier this year, following just a six-year tenure, making it one of the shortest-lived components in the index's history.

Market analysts' outlook on Walgreens, based on data from LSEG, paints a somber picture, with a consensus rating of 'hold' among Wall Street analysts and an anticipated rebound potential of merely 5% for its stock price.

Following closely is Intel, facing a grim trajectory as its stock price is projected to fall over 60% this year, marking its worst performance historically

Advertisements

Once a titan in the semiconductor industry, Intel finds itself ensnared in a quagmire as the technology landscape has undergone seismic shiftsOnce dominantly positioned in the chip market, it has increasingly been losing ground to rivals like Advanced Micro Devices, which steadily chip away at its market shareParticularly alarming is Intel's apparent lag in the competitive and rapidly-evolving field of artificial intelligence, where its failure to keep pace with its competitors has resulted in missed opportunities and sustained pressure on its performance.

The combination of internal strife and external challenges has led to mounting dissatisfaction among Intel's board members, which culminated in the departure of CEO Pat Gelsinger, who stepped down from his leadership role earlier this monthAdding to Intel's plight is its recent removal from the Dow index, replaced by tech powerhouse Nvidia, which further symbolizes a significant shift in the industry

• Financial Services Go Digital: Trends and Challenges
• Fed Cuts Rates, Dow Plunges 1,000 Points
• Can AI Drive Future Economic Growth?
• NVIDIA Market Valuation Surpasses $1 Trillion
• Is $1 Trillion About to Flow Back to A-Share Markets?

Intel’s troubles reflect broader challenges within the technology sector, calling into question its strategic direction moving forward.

Despite analysts from LSEG predominantly rating Intel as a 'hold,' indications of a potential turnaround remain, with projections suggesting more than a 26% upside in its stock price as of the last closing session.

Another notable underperformer is Moderna, which has seen its shares sink more than 60% this yearEmerging as a frontrunner during the COVID-19 pandemic as a vaccine innovator, Moderna now faces an uphill battle as the market landscape shifts under its feetThe vaccine frenzy that once propelled Moderna to new heights has dwindled, leading investor focus to pivot towards emerging markets, such as new and exciting weight-loss treatment manufacturersIn this changing scenario, Moderna’s strategy is under scrutiny.

The demand in European markets has remained lackluster, accompanied by significantly weakened purchasing power

In the U.S., the domestic vaccine market is fraught with heightened competition as new entrants continue to proliferateNavigating these turbulent waters, Moderna has opted for strategic realignment, which has included significant downward revisions in its annual sales guidance and an ambitious plan to cut costs by over $1 billion, striving for survival in what has become an increasingly challenging business environment.

HSBC analyst Yifeng Liu characterized the recent appointment of Robert FKennedy Jr., known for his vaccine skepticism, as the Secretary of Health and Human Services as a further concern weighing down on Moderna's prospectsWhile many analysts from the LSEG maintain a ‘hold’ rating on the stock, the average target price indicates a possible rebound of approximately 87%, suggesting that the storm might pass for Moderna in the foreseeable future.

The current market dynamics surrounding these three companies illustrate not just specific corporate struggles but also broader sectorial shifts and investor sentiments